Advertisement
Table 2 Hematological and organ responses
| ITT | Months post HDM/SCT | |||||
|---|---|---|---|---|---|---|
| 3 | 3 | 12 | 12 | 24 | 24 | |
| BD + HDM/SCT | HDM/SCT | BD + HDM/SCT | HDM/SCT | BD + HDM/SCT | HDM/SCT | |
| Number = 28 | Number = 28 | Number = 28 | Number = 28 | Number = 20 | Number = 23 | |
| CR | 15 (53.6%)a | 6 (21.4%) | 19 (67.9%)a | 10 (35.7%) | 14 (70%)a | 8 (34.8%) |
| VGPR | 4 (14.3%) | 4 (14.3%) | 2 (7.1%) | 3 (10.7%) | 1 (5%) | 1(4.3%) |
| PR | 3 (10.7%) | 4 (14.3%) | 3 (10.7%) | 2(2.1%) | 1 (5%) | 2 (8.7%) |
| NR | 6 (21.4%) | 12 (42.8%) | 2 (7.1%) | 6 (21.4%) | 2 (10%) | 3 (13.0%) |
| PD | - | - | 2 (7.1%) | 3 (10.7%) | 1 (5%) | 3 (13.0%) |
| Organ responses | ||||||
| Kidneyb | 65.2% (15/23) | 39.1% (9/23) | 75% (12/16) | 53.8% (7/13) | ||
| Heartb | 67% (10/15) | 25% (4/12) | 70% (7/10) | 50% (3/6) | ||
| Liverb | 100% (1/1) | 50% (1/2) | 100% (1/1) | 100% (1/1) | ||
| NSb | 100% (3/3) | 100% (2/2) | 100% (3/3) | 100% (2/2) | ||
